Inventor · disambiguated record
Marianne Lerbech Jensen
Also filed as: JENSEN MARIANNE L · JENSEN MARIANNE LERBECH
13 granted patents·11 pending applications·14 citations·filing 2002–2025
87Inventor score
Top patents by PatentIndex Score
24 records- 0195US11359197B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 14, 2022·4 cites·18 claims
- 0290US11279929B2Oligonucleotides for modulating Tau expressionHOFFMANN LA ROCHE·Filed 2019·Granted Mar 22, 2022·3 cites·13 claims
- 0389US11447775B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 20, 2022·3 cites·20 claims
- 0488US2025051777A1Oligonucleotides for modulating tau expressionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0588US2025136988A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0687US10799523B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Oct 13, 2020·3 cites·8 claims
- 0784US2024026360A1Oligonucleotides for modulating tau expressionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0881US12180478B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 0980US12163131B2Oligonucleotides for modulating Tau expressionHOFFMANN LA ROCHE·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 1075US11753640B2Oligonucleotides for modulating Tau expressionHOFFMANN LA ROCHE·Filed 2020·Granted Sep 12, 2023·0 cites·8 claims
- 1174US2025327072A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1270US2022143064A1Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1366US11058767B2CAMK2D antisense oligonucleotides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 13, 2021·0 cites·17 claims
- 1463US12241065B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·11 claims
- 1562US11077132B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Aug 3, 2021·0 cites·13 claims
- 1662US7282344B2Cation conducting GABAA receptors and their useNEUROSEARCH AS·Filed 2002·Granted Oct 16, 2007·1 cites·14 claims
- 1762US2025188463A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1857US2021378652A1Camk2d antisense oligonucleotides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1953US11485975B2Oligonucleotides for modulating TMEM106B expressionGENENTECH INC·Filed 2020·Granted Nov 1, 2022·0 cites·30 claims
- 2053US2008033061A1Cation conducting gabaa receptors and their useJENSEN MARIANNE L·Filed 2007·Application pending·0 cites
- 2153US2022213484A1Angptl2 antisense oligonucleotides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2243US11761951B2Methods of selecting therapeutic moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 19, 2023·0 cites·19 claims
- 2339US2018023081A1Lna oligonucleotides with alternating flanksBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2435US2012095056A12,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulatorsDAHL BJARNE H·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marianne Lerbech Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →